Company / Cash & Equivalents
MEDICAL PROPERTIES TRUST INC Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$332.3M
FY2025
5-year range
$235.7M / $1.5B
FY2021-FY2025
Trend
+41.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents returned to growth in FY2025 after 3 years of decline, reaching $332M.
Based on SEC 10-K filings.
$332M in FY2025 with a 5-year CAGR of -16.5%.
Declined from $459M to $332M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- -16.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -16.5%, indicating a declining trend.
- In FY2025, cash & equivalents increased 41.0% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
- Lowest cash & equivalents in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $332.3M | +41.0% |
| FY2024 | $235.7M | -48.7% |
| FY2023 | $459.2M | -16.5% |
| FY2022 | $549.9M | -62.4% |
| FY2021 | $1.5B | +78.1% |
| FY2020 | $820.9M | +378.7% |
| FY2019 | $171.5M | +106.0% |
| FY2018 | $83.2M | -57.4% |
| FY2017 | $195.5M | +35.3% |
| FY2016 | $144.5M | +214.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026